NYSE American: PTHS

Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE American under the ticker PTHS. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
PTHS
Exchange
NYSE American
SEC CIK
1919246
Official filings
SEC EDGAR

Research PTHS

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Pelthos Therapeutics Inc.'s stock ticker?

Pelthos Therapeutics Inc. trades under the ticker symbol PTHS on NYSE American. Its SEC Central Index Key (CIK) is 1919246.

Where can I read Pelthos Therapeutics Inc.'s SEC filings?

The PTHS SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Pelthos Therapeutics Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze PTHS's financial statements?

The PTHS Financials page shows Pelthos Therapeutics Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does PTHS compare with its peers and the market?

The PTHS Peer Comparison page lines Pelthos Therapeutics Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.